|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product sales, net | |||||
| License and Collaboration Agreement | |||||
| Royalty Income | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Impairment of acquired intangible assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (expense) income: | |||||
| Interest and other income, net | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Total other income, net | |||||
| Net loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive gain (loss): | |||||
| Unrealized gain (loss) on available-for-sale securities | |||||
| Comprehensive income (loss) | |||||
| Net loss per share: | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average common shares outstanding: | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...